Equities

Medico Remedies Ltd

MEDICO:NSI

Medico Remedies Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)47.40
  • Today's Change-0.600 / -1.25%
  • Shares traded31.12k
  • 1 Year change-32.29%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 10:44 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments152223
Total Receivables, Net498362376
Total Inventory163197181
Prepaid expenses------
Other current assets, total60645.50
Total current assets738645586
Property, plant & equipment, net214218161
Goodwill, net------
Intangibles, net1.210.70--
Long term investments7.617.940
Note receivable - long term----0
Other long term assets1.752.1515
Total assets962874762
LIABILITIES
Accounts payable315310271
Accrued expenses------
Notes payable/short-term debt687891
Current portion long-term debt/capital leases4.313.706.50
Other current liabilities, total412311
Total current liabilities428415379
Total long term debt8.67159.00
Total debt8198106
Deferred income tax1.431.860.30
Minority interest------
Other liabilities, total0.003.510.50
Total liabilities438436389
SHAREHOLDERS EQUITY
Common stock358272166
Additional paid-in capital------
Retained earnings (accumulated deficit)166166207
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity524438373
Total liabilities & shareholders' equity962874762
Total common shares outstanding838383
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.